News

     Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease marked by rapid progressive lung failure due to an accumulation of fibrotic collagen tissue. Due to the rapid onset of the disease, accurate and effective diagnostic tools are crucial for improving patient outcomes. Additionally, monitoring patient response to treatment should be minimally invasive...

Discover innovative strategies for treating osteosarcoma (OS) with localized drug delivery using Collagen Hybridizing Peptides (CHPs). OS, a malignant bone cancer, often requires surgery and chemotherapy, but these treatments are plagued by systemic side effects. This research highlights the potential of CHPs to selectively target tumors by binding to damaged collagen in bone tissue.

Atherosclerosis, characterized by the buildup of plaque inside human arteries, is one of the leading causes of cardiovascular diseases. The disease is brought on by a complex interplay between lipids, inflammatory cells, and the ECM. Arterial blood flow is restricted as plaques form, which can rupture to cause blockage. Arterial blockage, or occlusion, is...

Discover how collagen hybridizing peptides (CHPs) outperform Masson's trichrome in detecting collagen in idiopathic pulmonary fibrosis (IPF) tissues.

Discover how Collagen Hybridizing Peptides (CHPs) transform the diagnosis and treatment of cardiovascular diseases by accurately identifying and targeting damaged arterial collagen. Learn about this innovative technology and its impact on improving patient outcomes.

Collagen Hybridizing Peptides (CHPs) revolutionize liver fibrosis detection by halving biopsy analysis time. Explore detailed insights into collagen remodeling and deposition, which is directly linked to fibrotic activity.

Biliary Atresia (BA) is a severe liver disease in infants, often leading to cirrhosis and death. Collagen Hybridizing Peptides (CHP) offer diagnostic and prognostic insights, aiding treatment decisions and organ transplant allocation.

Explore more about the impact of obesity-related pre-diabetic hyperglycemia on bone healing using the DIO mouse model. CHPs help reveal that deficits in collagen microstructure leads to impaired fracture healing in obese subjects.